Isotopically Labelled Phosphatidylethanol Standards for LC-MS/MS Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current analytical methods for phosphatidylalkanols, such as phosphatidylethanol (PEth), face challenges in achieving accurate quantitative and qualitative analysis due to the need for improved standards and methods for identification, especially with increasing demands for precision.

Innovation Solution

Development of phosphatidylalkanol homologues with isotopically labelled glycerol moieties, specifically deuterated or 13C-isotoped, which serve as improved standards for analysis, including the use of deuterated or 13C-labelled compounds like PEth-16:0/18:1-d5 and PEth-16:0/18:1-13C3, and methods for their synthesis that avoid unwanted side reactions and impurities.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If deuterated or 13C-labelled phosphatidylalkanol homologues are used as internal standards, then measurement precision and reliability of PEth analysis is improved, but manufacturing complexity and cost increase

Engineering Contradiction:
Improveaccuracy of PEth analysisVSAvoidcomplexity of synthesis method
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The synthesis is divided into distinct stages: (1) preparation of isotopically labelled diacylglycerol from labelled glycerol, (2) phosphorylation to form the phosphatidylalkanol homologue. This segmentation allows each step to be optimized independently and facilitates quality control at each stage, resolving the contradiction between precision and complexity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The isotopic labelling is introduced at the very beginning with the glycerol moiety before any subsequent synthesis steps. This preliminary action ensures that the label is incorporated into the final product without requiring complex post-synthesis labelling steps, thereby improving measurement precision while managing synthesis complexity.

Inventive Principle:
Principle #10Preliminary action

2Ease of manufacture

If conventional synthesis methods are used for phosphatidylalkanol homologues, then ease of manufacture is maintained, but unwanted side reactions and impurities increase

Engineering Contradiction:
Improvesimplicity of synthesis methodVSAvoidpurity of product
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The synthesis employs specific parameter optimizations including: (1) use of isotopically labelled starting materials with defined purity, (2) controlled phosphorylation conditions to minimize side reactions, (3) purification steps tailored to remove specific impurities. These parameter changes maintain ease of manufacture while significantly improving product purity by preventing unwanted side reactions.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses intermediate compounds with protecting groups that prevent unwanted side reactions during synthesis. These intermediaries guide the reaction through controlled steps, ensuring high purity final product while maintaining reasonable manufacturing complexity through systematic protection-deprotection sequences.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If isotopically labelled standards are used, then sensitivity and reliability of analysis is improved, but loss of substance during preparation and analysis increases

Engineering Contradiction:
Improvereliability of analysisVSAvoidloss during sample preparation
Core Design Contradiction:
ReliabilityVSLoss of substance

Solution Approach 1:

The isotopic labelling (deuterium or 13C) fundamentally changes the physical and chemical parameters of the standard molecules, making them more stable and less susceptible to degradation during sample preparation and analysis. This parameter change reduces substance loss while maintaining reliability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The isotopically labelled homologues serve as exact structural copies of the endogenous phosphatidylethanol molecules, differing only in isotopic composition. This copying approach ensures identical behavior during sample preparation with the added benefit of enhanced stability and detectability, reducing loss while improving reliability.

Inventive Principle:
Principle #26Copying

Data Source

PatentUS20230393157A1Phosphatidylalkanol homologues having labelled moieties
Publication Date: 2023.12.07 CHIRON AS
  • US20230393157A1 patent drawing
  • US20230393157A1 patent drawing
  • US20230393157A1 patent drawing

AI summary

Phosphatidylalkanol homologues having isotopically labelled moieties, methods for preparation of isotopically labelled phosphatidylalkanol homologues and uses of isotopically labelled phosphatidylalkanol homologues.